Mitoxantrone MS treatment is one of only 2 shown effective for secondary progressive MS. This debilitating disease affects about 350,000 patients in the U.S. alone.  With Mitoxantrone, Multiple Sclerosis patients, especially those that suffer from the secondary progressive, progressive relapsing form of the disease.  As the name implies, each relapse becomes progressively worse, so preventing the relapses becomes of paramount importance.

About half of the patients originally diagnosed with MS will develop the secondary progressive, progressive relapsing form of MS.  This means that there is a progression of the disability and symptoms, and that the symptoms of each relapse is worse than the prior one, and they become more frequent – with less time of remission between flare ups.  Using Mitoxantrone, MS is treated by suppressing the activity of the white blood cells known as T cells and B cells, as well as macrophages.  All of these are thought to …